Waylis Therapeutics LLC drugs
4 results
Aciphex (rabeprazole sodium)
(rabeprazole sodium)Waylis Therapeutics LLC
Usage: ACIPHEX is indicated for the short-term treatment of erosive or ulcerative GERD in adults, maintenance of healing, symptomatic relief of GERD, healing of duodenal ulcers, eradication of H. pylori, treatment of pathological hypersecretory conditions, and symptomatic GERD in adolescents aged 12 and older for up to 8 weeks.
Humatin (paromomycin sulfate)
(PAROMOMYCIN SULFATE)Waylis Therapeutics LLC
Usage: Paromomycin sulfate is indicated for treating acute and chronic intestinal amebiasis and as adjunctive therapy in managing hepatic coma. It should be used to treat or prevent infections caused by susceptible bacteria to avoid drug resistance.
Lovaza (omega-3-acid ethyl esters)
(OMEGA-3-ACID ETHYL ESTERS)Waylis Therapeutics LLC
Usage: LOVAZA (omega-3-acid ethyl esters) is indicated as an adjunct to diet for reducing triglyceride levels in adults with severe hypertriglyceridemia (≥500 mg/dL). Patients should maintain a lipid-lowering diet and address contributing medical issues prior to treatment. Its effects on pancreatitis and cardiovascular outcomes are not established.
Myleran (busulfan)
(busulfan)Waylis Therapeutics LLC
Usage: MYLERAN (busulfan) is indicated for the palliative treatment of chronic myelogenous leukemia.